Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.

M, Dusinska; S, Boland; M, Saunders; L, Juillerat-Jeanneret; L, Tran; G, Pojana; A, Marcomini; K, Volkovova; J, Tulinska; LE, Knudsen; L, Gombau; M, Whelan; AR, Collins; F, Marano; C, Housiadas; D, Bilanicova; Kenzaoui B, Halamoda; Carreira S, Correia; Z, Magdolenova; LM, Fjellsbø; A, Huk; R, Handy; L, Walker; M, Barancokova; A, Bartonova; E, Burello; J, Castell; H, Cowie; M, Drlickova; R, Guadagnini; G, Harris; M, Harju; ES, Heimstad; M, Hurbankova; A, Kazimirova; Z, Kovacikova; M, Kuricova; A, Liskova; A, Milcamps; E, Neubauerova; T, Palosaari; P, Papazafiri; M, Pilou; MS, Poulsen; B, Ross; E, Runden-Pran; K, Sebekova; M, Staruchova; D, Vallotto; A, Worth

doi:10.3109/17435390.2014.991431

Public

Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.

Shared by NobleBlocks on May 1, 2015 • 12:00 AM UTC

Authors:

Dusinska M

Boland S

Saunders M

Abstract

In spite of recent advances in describing the health outcomes of exposure to nanoparticles (NPs), it still remains unclear how exactly NPs interact with their cellular targets. Size, surface, mass, geometry, and composition may all play a beneficial role as well as causing toxicity. Concerns of scie...

Subject

In vitro

Nanoparticles

Hazard Assessment

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!